Noncardiac Manifestations of Hereditary Amyloidosis

Sami L Khella1

  • 1Department of Neurology, Penn Presbyterian Medical Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Insights

Cardiac amyloidosis is a serious, underdiagnosed condition. Recognizing noncardiac symptoms early can lead to quicker diagnosis and better outcomes for patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Nephrology

Background:

  • Cardiac amyloidosis is a progressive and life-threatening condition.
  • It is frequently underrecognized, leading to delayed diagnosis and treatment.
  • Symptoms can affect multiple organs and mimic other common diseases.

Purpose of the Study:

  • To highlight the importance of noncardiac manifestations in early cardiac amyloidosis diagnosis.
  • To emphasize how recognizing these symptoms can improve patient prognosis.
  • To underscore the need for increased clinical awareness of this condition.

Main Methods:

  • Review of clinical presentations of cardiac amyloidosis.
  • Analysis of symptom timelines and diagnostic delays.
  • Correlation of noncardiac symptoms with cardiac involvement.

Main Results:

  • Noncardiac manifestations typically precede cardiac symptoms by several years.
  • Symptom overlap with other conditions complicates early diagnosis.
  • Delayed diagnosis is common due to the insidious and diverse nature of symptoms.

Conclusions:

  • Early recognition of noncardiac signs is crucial for timely diagnosis of cardiac amyloidosis.
  • Increased physician familiarity with diverse manifestations can improve patient outcomes.
  • Prompt diagnosis enables earlier treatment initiation, potentially altering the disease's progressive course.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
62
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.7K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
25
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
41
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
19